Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Leukemia & Lymphoma
|
June 12, 2019
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)
Anna Kalff, Tiffany Khong, Sridurga Mithraprabhu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma
Mingjun Zhang, Falon Gray, Ian Cushman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 5, 2021
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
Mark T Reding, Ingrid Pabinger, Pal Andre Holme, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 18, 2015
A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples
Yan Ren, Maria Wang, Suzana Couto, et al.
Leukemia
|
November 14, 2019
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Chad C Bjorklund, Jian Kang, Michael Amatangelo, et al.
British Journal of Haematology
|
August 4, 2017
Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicity
Patrick R Hagner, Hsiling Chiu, Maria Ortiz, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
March 18, 2009
Lyotropic liquid-crystalline solutions of high-concentration dispersions of single-walled carbon nanotubes with conjugated polymers
Hang Woo Lee, Wei You, Soumendra Barman, et al.
Cell Reports. Medicine
|
May 22, 2024
Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma
Michael Amatangelo, Erin Flynt, Nicholas Stong, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 1, 2010
Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas
Wenjun Zhang, Abigail McElhinny, Alma Nielsen, et al.
Methods (San Diego, Calif.)
|
September 3, 2010
The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays
Andrea Babic, Isabell R Loftin, Stacey Stanislaw, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Leukemia & Lymphoma
|
June 12, 2019
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)
Anna Kalff, Tiffany Khong, Sridurga Mithraprabhu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma
Mingjun Zhang, Falon Gray, Ian Cushman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 5, 2021
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
Mark T Reding, Ingrid Pabinger, Pal Andre Holme, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 18, 2015
A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples
Yan Ren, Maria Wang, Suzana Couto, et al.
Leukemia
|
November 14, 2019
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Chad C Bjorklund, Jian Kang, Michael Amatangelo, et al.
British Journal of Haematology
|
August 4, 2017
Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicity
Patrick R Hagner, Hsiling Chiu, Maria Ortiz, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
March 18, 2009
Lyotropic liquid-crystalline solutions of high-concentration dispersions of single-walled carbon nanotubes with conjugated polymers
Hang Woo Lee, Wei You, Soumendra Barman, et al.
Cell Reports. Medicine
|
May 22, 2024
Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma
Michael Amatangelo, Erin Flynt, Nicholas Stong, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 1, 2010
Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas
Wenjun Zhang, Abigail McElhinny, Alma Nielsen, et al.
Methods (San Diego, Calif.)
|
September 3, 2010
The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays
Andrea Babic, Isabell R Loftin, Stacey Stanislaw, et al.
Page
of 5